drugset / Trial / NCT02134405
Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia
Phase 4
Unknown
200 enrolled
University of Malaya
Second Affiliated Hospital, School of Medicine, Zhejiang University · collabZhejiang Provincial Hospital of TCM · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multi-Asian-centre randomised controlled trial of Rebamipide alone vs Rebamipide with Esomeprazole in the treatment of adult patients with Functional Dyspepsia. The hypothesis is that a combination therapy is superior to mono-therapy in the control of patients' symptoms and quality of life improvement.
Timeline
- Start
- 2014-08
- Primary completion
- 2016-06
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 20 mg | Oral |
| Subject | Rebamipide | Small molecule | 100 mg | Oral |